Search results
Kymera reports promising Phase 1 results for KT-333 cancer drug By Investing.com
Investing.com· 2 days agoKymera Therapeutics Inc. (NASDAQ: KYMR), a biopharmaceutical firm focused on advancing protein...
Cancer disappears in 100% of patients treated with new drug in promising clinical trial
Euronews via Yahoo News· 4 days agoA study showed a 100 per cent positive response rate in 42 patients with a specific type of rectal ...
Kate Middleton Is in UK Amid Rumors That She Was Receiving Cancer Treatment in Houston, Texas
ET Online via AOL· 3 days agoThere is rampant speculation that Kate Middleton is in the United States undergoing cancer...
More men 'should be told about blood test that can detect prostate cancer'
Daily Express· 4 days agoOutdated NHS guidance is “putting lives at risk” by preventing GPs from raising the option of a...
Princess Kate On Receiving Chemotherapy: “There Are Good Days and Bad Days”
Harper's Bazaar via Yahoo News· 1 day agoKate explained in her video message that because, following her surgery, doctors found that there...
Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug...
San Mateo Daily Journal· 4 days agoInvestor webcast on or before July 23 will include updates on Jaguar's cancer supportive care...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoAnd, last month, Pfizer unveiled positive results from a lung cancer study. The company tested its ...
UroGen Catapults On 'Unprecedented' Results For Gel-Based Cancer Drug
Investor's Business Daily· 2 days agoUroGen stock rocketed Thursday on "unprecedented" test results for its bladder cancer treatment, a...
Virtua Health offers innovative lung cancer-fighting drug
NJBIZ· 6 days agoMarlton-headquartered Virtua Health is the first South Jersey provider to offer a groundbreaking ...
Warning over habitual delays for cancer treatment
BBC via AOL· 3 days ago[Getty Images] Long waits for cancer care are becoming routine across the UK with nearly half of all specialist cancer centres experiencing delays most...